GlobalData has released its pharma report, “PharmaPoint: Crohn’s Disease Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn’s Disease Market. The report identifies and analyses […]
January 2014 Life Science Industry Research Reports
PharmaPoint: Crohn’s Disease – Global Drug Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as – Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab) Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab) These compounds will challenge the […]
PharmaPoint: Type 2 Diabetes – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update
The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period. The […]
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines – Global Drug Forecast and Market Analysis to 2022
Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 […]
PharmaPoint: Crohn’s Disease – China Drug Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into […]
PharmaPoint: Crohn’s Disease – Canada Drug Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into […]
PharmaPoint: Crohn’s Disease – 5EU Drug Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into […]
Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition
The market for pet medications in the U.S. is experiencing considerable activity. Longtime flea and tick leader Frontline (from Merial) is finally feeling the effects of the patent expiration of its active ingredient, fipronil. Several other fipronil products have made […]
Vercirnon (Crohn’s Disease) – Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into […]
Tysabri (Crohn’s Disease) – Forecast and Market Analysis to 2022
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into […]
Stay In Touch